DE1900367A1 - Stabile Glucagonloesung und Verfahren zu ihrer Herstellung - Google Patents

Stabile Glucagonloesung und Verfahren zu ihrer Herstellung

Info

Publication number
DE1900367A1
DE1900367A1 DE19691900367 DE1900367A DE1900367A1 DE 1900367 A1 DE1900367 A1 DE 1900367A1 DE 19691900367 DE19691900367 DE 19691900367 DE 1900367 A DE1900367 A DE 1900367A DE 1900367 A1 DE1900367 A1 DE 1900367A1
Authority
DE
Germany
Prior art keywords
glucagon
solution
months
detergent
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691900367
Other languages
German (de)
English (en)
Inventor
Jan Markussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Terapeutisk Laboratorium AS
Original Assignee
Novo Terapeutisk Laboratorium AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Terapeutisk Laboratorium AS filed Critical Novo Terapeutisk Laboratorium AS
Publication of DE1900367A1 publication Critical patent/DE1900367A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
DE19691900367 1968-01-10 1969-01-04 Stabile Glucagonloesung und Verfahren zu ihrer Herstellung Pending DE1900367A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0536/68A GB1202607A (en) 1968-01-10 1968-01-10 Improvements in or relating to stable glucagon solutions and their preparation

Publications (1)

Publication Number Publication Date
DE1900367A1 true DE1900367A1 (de) 1969-09-04

Family

ID=9723689

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691900367 Pending DE1900367A1 (de) 1968-01-10 1969-01-04 Stabile Glucagonloesung und Verfahren zu ihrer Herstellung

Country Status (7)

Country Link
AT (1) AT283600B (pt)
BE (1) BE726681A (pt)
DE (1) DE1900367A1 (pt)
FR (1) FR2000114A1 (pt)
GB (1) GB1202607A (pt)
IT (1) IT974528B (pt)
NL (1) NL6900460A (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001185A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Stabilized pharmaceutical peptide compositions

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235627B2 (en) 1996-08-30 2007-06-26 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6458924B2 (en) 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6384016B1 (en) * 1998-03-13 2002-05-07 Novo Nordisk A/S Stabilized aqueous peptide solutions
JP4072319B2 (ja) * 1998-03-13 2008-04-09 ノヴォ ノルディスク アクティーゼルスカブ 安定化水溶性ペプチド溶液
US9610329B2 (en) 2009-10-22 2017-04-04 Albireo Pharma, Inc. Stabilized glucagon solutions
WO2011049713A2 (en) 2009-10-22 2011-04-28 Biodel Inc. Stabilized glucagon solutions
JP5894174B2 (ja) * 2010-11-03 2016-03-23 アレコー リミテッド グルカゴンを含む新規組成物
US9198971B2 (en) 2012-01-09 2015-12-01 Adocia Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acid
US20150314003A2 (en) 2012-08-09 2015-11-05 Adocia Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer
WO2017211917A1 (fr) * 2016-06-07 2017-12-14 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide statistique
FR3052071B1 (fr) * 2016-06-07 2018-09-07 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon et un co-polyaminoacide
FR3061660B1 (fr) * 2017-01-10 2019-05-31 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
GB201611077D0 (en) 2016-06-24 2016-08-10 Arecor Ltd Novel composition
WO2019110838A1 (fr) 2017-12-07 2019-06-13 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
MX2020005915A (es) 2017-12-07 2020-10-19 Adocia Composiciones en forma de una solución acuosa inyectable que comprende glucagón humano y un copoliaminoácido.
CN111670042A (zh) 2017-12-07 2020-09-15 阿道恰公司 包含人胰高血糖素和共聚氨基酸的可注射水溶液形式的组合物
FR3074683B1 (fr) * 2017-12-07 2020-01-10 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
FR3083087A1 (fr) 2018-06-29 2020-01-03 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
US10987426B2 (en) * 2017-12-07 2021-04-27 Adocia Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
FR3067247A1 (fr) 2018-06-07 2018-12-14 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2643967A (en) * 1946-08-31 1953-06-30 Wallerstein Co Inc Concentrate of tyrothricin and its therapeutically active components
NL94376C (nl) * 1958-04-28 1960-05-16 Nv Organon Werkwijze ter bereiding van injicieerbare glacagonpreparaten met verlengde werking

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001185A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Stabilized pharmaceutical peptide compositions
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions

Also Published As

Publication number Publication date
NL6900460A (pt) 1969-07-14
GB1202607A (en) 1970-08-19
FR2000114A1 (fr) 1969-08-29
IT974528B (it) 1974-07-10
BE726681A (pt) 1969-07-09
AT283600B (de) 1970-08-10

Similar Documents

Publication Publication Date Title
DE1900367A1 (de) Stabile Glucagonloesung und Verfahren zu ihrer Herstellung
DE2036114C3 (de) Wäßriges Tetramisolpräparat
DE2324386C2 (de) Wäßriger Cholestrin-Standard
DE2855851C2 (de) Stabilisierte Addukte von Vitamin-K-Verbindungen mit organischen Verbindungen, Verfahren zu deren Herstellung und deren Verwendung
DE3000743C2 (de) Arzneipräparat auf der Basis eines Salzes der Acetylsalicylsäure und einer basischen Aminosäure
DE1045377C2 (de) Verfahren zum Stabilisieren von zur Herstellung von Fungiziden geeignetem Selendisulfid, das durch Zusatz eines hydrophilen kolloidalen Suspensionsmittels aktiviert ist
DE3112272C2 (pt)
DE1807255A1 (de) Praeparat aus hinsichtlich ihrer Anzahl,Form und Volumen stabilisierter Suspensionen von organischen Partikelchen zur Konservierung mikroskopischer Partikelchen und zum Herstellen standardisierter Partikelchen-Suspensionen
DE1470128A1 (de) Derivate von Vitamin K3
DE1467749A1 (de) Verfahren zur Herstellung von stabilen Tetracyclinpraeparaten
DE69332039T2 (de) Hochkonzentrierte Aminosäurelösung
DE68902755T2 (de) Antineoplastische formulierungen.
DE865451C (de) Verfahren zur Herstellung von Diazoloesungen und leichtloeslicher Diazosalzpraeparate aus festen Diazoniumchlorid-Metallchlorid-Doppelsalzen
DE19540788A1 (de) Verwendung von wässrigen L-Tryptophan- und/oder L-Threonin-Salzlösungen
DE1911609C3 (de) Fotografische Fixiersalzmischung
DE964632C (de) Verfahren zur Herstellung farbbestaendiger, haltbarer Streptomycinloesungen hoher Wirksamkeit
DE689180C (de) Desinfektionsmittel
DE1179378B (de) Verfahren zur Herstellung von wasserloeslichen, titrierbares Jod und als Traeger einPoly-[3-vinyl-5-methyloxazolidon-(2)] enthaltenden Kom-plexverbindungen
DE2036113A1 (de) Tetramisolpraparate
DE2163062C3 (de) Mittel zum Frischhalten von Schnittblumen
DE3503206C2 (pt)
DE1767135B1 (de) Stabiles,festes D-Glucosaccharo-1,4-lacton oder dessen Salz enthaltendes Arzneimittel
DE1908078B1 (de) Biocide Zubereitung
DE1053734B (de) Verfahren zur Loeslichmachung und Stabilisierung der Tetracyclinantibiotika
DE915851C (de) Verfahren zur Herstellung von Tyrothricin und Streptomycin bzw. Dihydrostreptomycin enthaltenden Loesungen